Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
717.23
+4.46 (0.63%)
May 12, 2026, 11:02 AM EDT - Market open

Regeneron Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
4,4234,5054,4133,9544,3388,075
Depreciation & Amortization
540543.7482.9421341.4286.2
Stock-Based Compensation
995.4993.7982.8885725601.7
Other Adjustments
-1,386-1,596-839.5-571.5-146.634.6
Change in Receivables
-158.5498.1-554-338.8707.8-1,927
Changes in Inventories
-96.4-275.3-619.7-271.7-696.5-494.3
Changes in Accounts Payable
1,059736.8735.1598.6-138.4866.1
Changes in Unearned Revenue
30.2-51.7227.837.932.4-120.2
Changes in Other Operating Activities
-394.4-375.3-407.5-120.1-148.6-240.7
Operating Cash Flow
5,0134,9794,4214,5945,0157,081
Operating Cash Flow Growth
26.80%12.63%-3.78%-8.39%-29.18%170.47%
Capital Expenditures
-899.7-898.4-755.9-718.6-590.1-551.9
Sale of Property, Plant & Equipment
--20.1---
Purchases of Intangible Assets
-322-315.3-125.7-207.8-1,027-
Purchases of Investments
-11,175-10,958-16,617-11,646-7,488-7,048
Proceeds from Sale of Investments
10,69411,54615,0279,4425,5512,215
Payments for Business Acquisitions
-3.3-3.3-16.5-54.9-230.3-
Investing Cash Flow
-1,706-629.1-2,468-3,185-3,785-5,385
Issuance of Common Stock
738.4635.91,4651,1461,5201,672
Repurchase of Common Stock
-3,793-3,971-3,632-2,936-2,529-2,678
Net Common Stock Issued (Repurchased)
-3,054-3,335-2,167-1,790-1,009-1,006
Common Dividends Paid
-374.3-370.3----
Other Financing Activities
--10.3-33.4---
Financing Cash Flow
-3,428-3,715-2,201-1,790-1,009-1,006
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-1.20.3-0.7-0.4--
Net Cash Flow
-122.4634.7-248.8-381.6221.3690.8
Free Cash Flow
4,1134,0813,6653,8754,4256,529
Free Cash Flow Growth
0.80%11.35%-5.44%-12.42%-32.23%225.90%
FCF Margin
27.57%28.45%25.80%29.54%36.35%40.63%
Free Cash Flow Per Share
38.1737.5731.8434.0838.9858.19
Levered Free Cash Flow
4,6624,1854,0753,9013,1397,821
Unlevered Free Cash Flow
3,3512,7613,3473,7573,0327,492
Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q